Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.
D000293:Adolescent; D000328:Adult; D000631:Aminopyridines / Q000627:therapeutic use*; D000676:Amrinone; D001794:Blood Pressure / Q000187:drug effects; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000378:metabolism*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D011669:Pulmonary Wedge Pressure; D014655:Vascular Resistance / Q000187:drug effects
D000631:Aminopyridines; D007773:Lactates; D019344:Lactic Acid; D000676:Amrinone